IJERPH, Vol. 20, Pages 2797: The Place of Botulinum Toxin in Spastic Hemiplegic Shoulder Pain after Stroke: A Scoping Review
IJERPH, Vol. 20, Pages 2797: The Place of Botulinum Toxin in Spastic Hemiplegic Shoulder Pain after Stroke: A Scoping Review
International Journal of Environmental Research and Public Health doi: 10.3390/ijerph20042797
Authors:
Pieter Struyf
Lisa Tedesco Triccas
Fabienne Schillebeeckx
Filip Struyf
Stroke is a common pathology worldwide, with an age-standardized global rate of new strokes of 150.5 per 100,000 population in 2017. Stroke causes upper motor neuron impairment leading to a spectrum of muscle weakness around the shoulder joint, changes in muscle tone, and subsequent soft tissue changes. Hemiplegic shoulder pain (HSP) is the most common pain condition in stroke patients and one of the four most common medical complications after stroke. The importance of the appropriate positioning and handling of the hemiplegic shoulder for prevention of HSP is therefore of high clinical relevance. Nevertheless, HSP remains a frequent and disabling problem after stroke, with a 1-year prevalence rate up to 39%. Furthermore, the severity of the motor impairment is one of the most important identified risk factors for HSP in literature. Spasticity is one of these motor impairments that is likely to be modifiable. After ruling out or treating other shoulder pathologies, spasticity must be assessed and treated because it could lead to a cascade of unwanted complications, including spastic HSP. In clinical practice, Botulinum toxin A (BTA) is regarded as the first-choice tre...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Pieter Struyf Lisa Tedesco Triccas Fabienne Schillebeeckx Filip Struyf Tags: Review Source Type: research
More News: Brain | Environmental Health | International Medicine & Public Health | Motor Neurone Disease | Neurology | Pain | Pathology | Stroke